It was recently shown that myo-inositol can decrease IL-6 expression by regulating the IRE1 and STAT3 pathways, and thereby improve oxygenation in patients with severe ARDS caused by SARS-CoV-2 infection [8]. Here, IL6 is linked to acute respiratory distress syndrome.